• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.1型人类免疫缺陷病毒(HIV-1)完整病毒体的免疫反应性表明,HIV-1免疫型的数量少于基因型。
J Virol. 2000 Nov;74(22):10670-80. doi: 10.1128/jvi.74.22.10670-10680.2000.
2
Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.M组完整、天然、原代人类免疫缺陷病毒1型病毒体上保守且暴露的表位。
J Virol. 2000 Aug;74(15):7096-107. doi: 10.1128/jvi.74.15.7096-7107.2000.
3
Defining human immunodeficiency virus (HIV) type 1 immunotypes with six human monoclonal antibodies.利用六种人源单克隆抗体定义1型人类免疫缺陷病毒(HIV)免疫型。
AIDS Res Hum Retroviruses. 2004 Jan;20(1):55-65. doi: 10.1089/088922204322749503.
4
Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIV.1型人类免疫缺陷病毒(HIV)的免疫分型:一种HIV免疫分类方法
J Virol. 1999 May;73(5):4042-51. doi: 10.1128/JVI.73.5.4042-4051.1999.
5
Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1.完整的1型人类免疫缺陷病毒(HIV-1)病毒粒子上暴露表位的定位:一种研究HIV-1免疫相关性的新策略。
J Virol. 1998 Nov;72(11):9384-91. doi: 10.1128/JVI.72.11.9384-9391.1998.
6
A virus binding assay for studying the antigenic landscape on intact, native, primary human immunodeficiency virus-type 1.一种用于研究完整、天然的原发性1型人类免疫缺陷病毒抗原格局的病毒结合试验。
J Immunol Methods. 2001 Jul 1;253(1-2):253-62. doi: 10.1016/s0022-1759(01)00384-2.
7
Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.抗体与原发性人类免疫缺陷病毒1型(HIV-1)分离株的病毒体相关gp120分子的结合:对巨噬细胞和外周血单核细胞HIV-1感染的影响。
Virology. 1997 Mar 17;229(2):360-9. doi: 10.1006/viro.1997.8443.
8
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.在CCR5限制性而非CXCR4利用型的原发性人类免疫缺陷病毒1型毒株的天然包膜糖蛋白寡聚体中,一个保守的、CD4诱导性V3环中和表位的隐秘性质。
J Virol. 2005 Jun;79(11):6957-68. doi: 10.1128/JVI.79.11.6957-6968.2005.
9
Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.对V3构象敏感表位具有特异性的人源单克隆抗体可中和来自不同进化枝的1型人类免疫缺陷病毒原始分离株。
J Virol. 2002 Sep;76(18):9035-45. doi: 10.1128/jvi.76.18.9035-9045.2002.
10
Patterns of conserved gp120 epitope presentation on attached HIV-1 virions.附着的 HIV-1 病毒颗粒上保守 gp120 表位呈现的模式。
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9893-E9902. doi: 10.1073/pnas.1705074114. Epub 2017 Oct 30.

引用本文的文献

1
Neutralization of Dengue Virus Serotypes by Sera from Dengue-Infected Individuals Is Preferentially Directed to Heterologous Serotypes and Not against the Autologous Serotype Present in Acute Infection.感染登革热个体的血清对不同血清型的登革热病毒具有中和作用,而不是针对急性感染中存在的自身血清型。
Viruses. 2021 Sep 29;13(10):1957. doi: 10.3390/v13101957.
2
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.来自不同进化枝的HIV-1包膜糖蛋白可区分疫苗接种者的抗体反应和持久性。
J Virol. 2018 Mar 28;92(8). doi: 10.1128/JVI.01843-17. Print 2018 Apr 15.
3
Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera.利用HIV-1长期不进展者血清进行可识别生物标志物及治疗开发。
BMC Immunol. 2015 Apr 28;16:25. doi: 10.1186/s12865-015-0094-z.
4
Topological analysis of HIV-1 glycoproteins expressed in situ on virus surfaces reveals tighter packing but greater conformational flexibility than for soluble gp120.在病毒表面原位表达的 HIV-1 糖蛋白的拓扑分析表明,与可溶性 gp120 相比,其组装更紧密,但构象灵活性更大。
J Virol. 2013 Aug;87(16):9233-49. doi: 10.1128/JVI.01145-13. Epub 2013 Jun 5.
5
Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteins.人类免疫缺陷病毒 1 型单价或三价包膜糖蛋白诱导的猕猴中和抗体反应。
PLoS One. 2013;8(3):e59803. doi: 10.1371/journal.pone.0059803. Epub 2013 Mar 22.
6
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial.分析在 ALVAC/AIDSVAX HIV-1 疫苗功效试验中疫苗接种者诱导产生的 V2 抗体反应。
PLoS One. 2013;8(1):e53629. doi: 10.1371/journal.pone.0053629. Epub 2013 Jan 17.
7
Binding of anti-membrane-proximal gp41 monoclonal antibodies to CD4-liganded and -unliganded human immunodeficiency virus type 1 and simian immunodeficiency virus virions.抗膜近端 gp41 单克隆抗体与 CD4 配体结合和未配体结合的人类免疫缺陷病毒 1 型和猴免疫缺陷病毒病毒颗粒的结合。
J Virol. 2012 Feb;86(3):1820-31. doi: 10.1128/JVI.05489-11. Epub 2011 Nov 16.
8
The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization.氨基酸变化在人类免疫缺陷病毒 1 型跨膜域中对抗体结合和中和的作用。
Virology. 2011 Dec 20;421(2):235-44. doi: 10.1016/j.virol.2011.09.032. Epub 2011 Oct 24.
9
SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development?猿猴免疫缺陷病毒感染可保护猕猴免受异源致病性猿猴免疫缺陷病毒攻击:这是人类免疫缺陷病毒1型疫苗研发的金标准吗?
Curr HIV Res. 2009 Sep;7(5):497-503. doi: 10.2174/157016209789346255.
10
HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen.人类免疫缺陷病毒1型疫苗设计:利用多种淋巴细胞攻克多样病原体。
Hum Vaccin. 2009 Apr;5(4):268-71. doi: 10.4161/hv.5.4.7706.

本文引用的文献

1
Binary classification by stochastic neural nets.随机神经网络的二元分类
IEEE Trans Neural Netw. 1995;6(2):488-91. doi: 10.1109/72.363484.
2
F.D.A. authorizes first full testing for H.I.V. vaccine.美国食品药品监督管理局批准首次对艾滋病病毒疫苗进行全面测试。
N Y Times Web. 1998 Jun 4:A1, A23.
3
A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates.一种用于人类的人类免疫缺陷病毒初免-加强免疫方案可诱导产生具有不同分支间交叉反应性并能中和多种X4、R5和双嗜性B和C分支主要分离株的抗体。
J Virol. 2000 Nov;74(21):10025-33. doi: 10.1128/jvi.74.21.10025-10033.2000.
4
Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.M组完整、天然、原代人类免疫缺陷病毒1型病毒体上保守且暴露的表位。
J Virol. 2000 Aug;74(15):7096-107. doi: 10.1128/jvi.74.15.7096-7107.2000.
5
A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex.1型人类免疫缺陷病毒的全球中和抗性表型由介导包膜复合物感染性增强和构象变化的不同机制决定。
J Virol. 2000 May;74(9):4183-91. doi: 10.1128/jvi.74.9.4183-4191.2000.
6
The implications of antigenic diversity for vaccine development.抗原多样性对疫苗研发的影响。
Immunol Lett. 1999 Mar;66(1-3):159-64. doi: 10.1016/s0165-2478(98)00176-x.
7
Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIV.1型人类免疫缺陷病毒(HIV)的免疫分型:一种HIV免疫分类方法
J Virol. 1999 May;73(5):4042-51. doi: 10.1128/JVI.73.5.4042-4051.1999.
8
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.针对细小病毒B19蛋白产生中和性人单克隆抗体。
J Virol. 1999 Mar;73(3):1974-9. doi: 10.1128/JVI.73.3.1974-1979.1999.
9
Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1.完整的1型人类免疫缺陷病毒(HIV-1)病毒粒子上暴露表位的定位:一种研究HIV-1免疫相关性的新策略。
J Virol. 1998 Nov;72(11):9384-91. doi: 10.1128/JVI.72.11.9384-9391.1998.
10
Identification of a new human immunodeficiency virus type 1 distinct from group M and group O.鉴定出一种不同于M组和O组的新型人类免疫缺陷病毒1型。
Nat Med. 1998 Sep;4(9):1032-7. doi: 10.1038/2017.

1型人类免疫缺陷病毒(HIV-1)完整病毒体的免疫反应性表明,HIV-1免疫型的数量少于基因型。

Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.

作者信息

Nyambi P N, Nádas A, Mbah H A, Burda S, Williams C, Gorny M K, Zolla-Pazner S

机构信息

Department of Pathology, New York University School of Medicine, New York, New York 10016, USA.

出版信息

J Virol. 2000 Nov;74(22):10670-80. doi: 10.1128/jvi.74.22.10670-10680.2000.

DOI:10.1128/jvi.74.22.10670-10680.2000
PMID:11044111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC110941/
Abstract

In order to protect against organisms that exhibit significant genetic variation, polyvalent vaccines are needed. Given the extreme variability of human immunodeficiency virus type 1 (HIV-1), it is probable that a polyvalent vaccine will also be needed for protection from this virus. However, to understand how to construct a polyvalent vaccine, serotypes or immunotypes of HIV must be identified. In the present study, we have examined the immunologic relatedness of intact, native HIV-1 primary isolates of group M, clades A to H, with human monoclonal antibodies (MAbs) directed at epitopes in the V3, C5, and gp41 cluster I regions of the envelope glycoproteins, since these regions are well exposed on the virion surface. Multivariate analysis of the binding data revealed three immunotypes of HIV-1 and five MAb groups useful for immunotyping of the viruses. The analysis revealed that there are fewer immunotypes than genotypes of HIV and that clustering of the isolates did not correlate with either genotypes, coreceptor usage (CCR5 and CXCR4), or geographic origin of the isolates. Further analysis revealed distinct MAb groups that bound preferentially to HIV-1 isolates belonging to particular immunotypes or that bound to all three immunotypes; this demonstrates that viral immunotypes identified by mathematical analysis are indeed defined by their immunologic characteristics. In summary, these results indicate (i) that HIV-1 immunotypes can be defined, (ii) that constellations of epitopes that are conserved among isolates belonging to each individual HIV-1 immunotype exist and that these distinguish each of the immunotypes, and (iii) that there are also epitopes that are routinely shared by all immunotypes.

摘要

为了抵御表现出显著基因变异的生物体,需要多价疫苗。鉴于1型人类免疫缺陷病毒(HIV-1)的极端变异性,很可能也需要一种多价疫苗来预防这种病毒。然而,要了解如何构建多价疫苗,必须识别HIV的血清型或免疫型。在本研究中,我们检测了M组A至H亚型完整、天然的HIV-1原始分离株与针对包膜糖蛋白V3、C5和gp41簇I区域表位的人单克隆抗体(MAb)之间的免疫相关性,因为这些区域在病毒粒子表面充分暴露。对结合数据的多变量分析揭示了HIV-1的三种免疫型和五个可用于病毒免疫分型的MAb组。分析表明,HIV的免疫型比基因型少,并且分离株的聚类与基因型、共受体使用情况(CCR5和CXCR4)或分离株的地理来源均无相关性。进一步分析揭示了不同的MAb组,它们优先结合属于特定免疫型的HIV-1分离株或结合所有三种免疫型;这表明通过数学分析确定的病毒免疫型确实由其免疫特征所定义。总之,这些结果表明:(i)HIV-1免疫型可以被定义;(ii)在属于每种HIV-1免疫型的分离株中存在保守的表位组合,这些组合区分了每种免疫型;(iii)也存在所有免疫型都常规共有的表位。